This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Autotac Bio, Korea Research Institute of Bioscience and Biotechnology. Active years: 2019-2022.
Company Filing History:
1 out of 1 
1 out of 334 
Years Active: 2019-2022
Title: Hyunjoo Cha: Innovator in Anti-inflammatory and Neurodegenerative Disease Research
Introduction
Hyunjoo Cha is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the fields of anti-inflammatory and neurodegenerative disease research. With a total of 2 patents, his work focuses on innovative compositions and methods for treating various health conditions.
Latest Patents
Hyunjoo Cha's latest patents include an anti-inflammatory composition comprising an acylhydrazone derivative. This invention relates to a composition for preventing, alleviating, or treating inflammatory diseases. The active ingredient effectively inhibits inflammatory cytokines and signaling pathways, thereby alleviating symptoms of conditions such as dermatitis. Another notable patent addresses the prevention and treatment of neurodegenerative diseases through autophagy activity. This invention utilizes a synthetic ligand or arginylated BiP binding to the P62 ZZ domain to target and degrade misfolded proteins, which are associated with neurodegenerative disorders.
Career Highlights
Hyunjoo Cha has worked with esteemed organizations such as the Korea Research Institute of Bioscience and Biotechnology and Autotac Bio. His research has led to advancements in understanding and treating complex diseases, showcasing his dedication to improving health outcomes.
Collaborations
Hyunjoo Cha has collaborated with notable colleagues, including Bo Yeon Kim and Mija Ahn, who have contributed to his research endeavors. Their teamwork has fostered an environment of innovation and discovery in the field.
Conclusion
Hyunjoo Cha's contributions to the fields of anti-inflammatory and neurodegenerative disease research highlight his role as a leading inventor. His innovative patents and collaborations reflect his commitment to advancing medical science and improving patient care.